Invicta Diagnostic Limited Commences Operations at Pune Centre
Invicta Diagnostic Limited (NSE: INVICTA) has announced the start of commercial operations at its new diagnostic centre in Pune, effective 30 June 2026. The centre is operated through its subsidiary, Porteus Medical LLP, and marks the company's second location outside the Mumbai Metropolitan Region, following its Nashik centre.
The Pune facility offers a comprehensive range of diagnostic services, including MRI, mammography, CT scan, sonography (SONO), pathology, TMT, and X-ray. This integrated radiology and pathology model allows patients to access multiple services under one roof.
Strategic Expansion Beyond Mumbai
The expansion aligns with Invicta Diagnostic's long-term strategy to replicate its successful Mumbai operating model in high-potential urban markets. By partnering with reputed local clinicians, the company aims to accelerate market penetration and build a scalable diagnostic network across Maharashtra.
With this addition, Invicta Diagnostic Limited and its subsidiaries now operate 10 diagnostic centres and one centralised laboratory, enhancing its integrated healthcare delivery platform.
Management Commentary
Commenting on the development, Mr. Sanket Vinod Jain, Chairman and Non-Executive Director of Invicta Diagnostic Limited, said: "We are delighted to commence commercial operations at our Pune Centre through our subsidiary, Porteus Medical LLP. This is our second diagnostic centre outside the Mumbai Metropolitan Region after our Nashik Centre and reflects our continued commitment to making high-quality diagnostic services more accessible while strengthening our presence across Maharashtra."
Mr. Jain added: "With rising healthcare awareness, increasing demand for preventive and diagnostic testing, and favourable industry tailwinds, we remain confident in the long-term growth opportunity for the diagnostics sector. We will continue to expand our network through a scalable and integrated diagnostic model while delivering reliable, technology-driven healthcare services to patients."
Operational Network and Business Model
Invicta Diagnostic Limited operates under the consumer-facing brand PC Diagnostics, providing radiology and pathology solutions. Its network comprises 10 diagnostic centres and one centralised laboratory across the MMR region in Maharashtra. This includes one flagship hub in Thane with full testing capabilities, six additional hub centres offering advanced and basic diagnostics, and three spoke centres focused on basic diagnostics and sample collection, all supported by a centralised laboratory.
The company's hub-and-spoke model is designed for efficiency, reach, and patient convenience. Services include home sample collection, house calls, and multiple report delivery options.
Financial Performance and Listing
Invicta Diagnostic Limited was listed on NSE Emerge on 8 December 2025. For the financial year 2026, the company recorded a consolidated revenue of ₹33.04 crore, an EBITDA of ₹10.45 crore, and a net profit of ₹4.87 crore.
The company continues to strengthen its presence in the Mumbai Metropolitan Region while expanding across Maharashtra's diagnostic market, guided by its focus on quality, affordability, and consistent patient care.
